Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Gross Profit (2016 - 2025)

Ptc Therapeutics (PTCT) has 10 years of Gross Profit data on record, last reported at $157.7 million in Q4 2025.

  • For Q4 2025, Gross Profit fell 19.89% year-over-year to $157.7 million; the TTM value through Dec 2025 reached $1.7 billion, up 383.26%, while the annual FY2025 figure was $1.7 billion, 124.67% up from the prior year.
  • Gross Profit reached $157.7 million in Q4 2025 per PTCT's latest filing, down from $1.2 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.2 billion in Q1 2025 and bottomed at -$225.6 million in Q2 2024.
  • Average Gross Profit over 5 years is $205.9 million, with a median of $171.8 million recorded in 2024.
  • Peak YoY movement for Gross Profit: tumbled 212.22% in 2024, then skyrocketed 495.38% in 2025.
  • A 5-year view of Gross Profit shows it stood at $155.9 million in 2021, then increased by 0.4% to $156.5 million in 2022, then skyrocketed by 77.57% to $277.9 million in 2023, then decreased by 29.16% to $196.9 million in 2024, then decreased by 19.89% to $157.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $157.7 million in Q4 2025, $1.2 billion in Q1 2025, and $196.9 million in Q4 2024.